NeuroX1 Company

NeuroX1 is a computational drug design startup building a platform to identify drivers of neurodegenerative/neurological diseases then using Chiron, a propritary generative chemistry platform, designs novel compounds for those diseases.

Last Funding Type: Seed
Funding Status: Seed
Headquarters: Austin, Texas, United States
Founded Date: 2021-11-18
Last Funding Date: 2023-03-03
Total Funding: 1750000.0
Investors Number: 3.0
Industry: Neurodegenerative disease diagnosis and treatment